Evidence map›Paper›PMID 42781687›Full record

ArticleTransplantation direct2026

Thirty Years and Beyond: Long-term Outcomes After Liver Transplantation at a Single Center: Progress, Challenges, and Future Implications.

Nora Nevermann, Anna Riddermann, Ulrike Bode, Philipp Felgendreff, Markus Quante, Nicolas Richter, Linda Feldbrügge, Heiner Wedemeyer, Richard Taubert, Dieter Haffner and 5 more

Abstract read
In one paragraph

Article in Transplantation direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nora NevermannDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0000-0003-0063-9296
Anna RiddermannDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Ulrike BodeDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Philipp FelgendreffDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Markus QuanteDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Nicolas RichterDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Linda FeldbrüggeDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Heiner WedemeyerDepartment of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
Richard TaubertDepartment of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.
Dieter HaffnerDepartment of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany.
Eva-Doreen PfisterDepartment of Pediatric Kidney, Liver, Metabolic and Neurological Diseases, Hannover Medical School, Hannover, Germany.
Ulrich BaumannDivision of Pediatric Gastroenterology and Hepatology, Department of Pediatric Kidney, Liver, Metabolic, and Neurological Diseases, Hannover Medical School, Hannover, Germany.
Katrin SplithDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Moritz SchmelzleDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.ORCID https://orcid.org/0009-0007-1448-173X
Burckhardt RingeDepartment of General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The liver transplantation (LT) program was established at Hannover Medical School in 1972. The aim of the study was to assess graft and patient survival, organ function, and active life throughout ≥3 decades after LT, with a special focus on recipients surviving ≥30 y after transplantation. Methods: Clinical data from all consecutive patients undergoing LT between 1972 and 1994 were collected in a prospective design, and outcome data were complemented retrospectively. Results: Nine hundred LTs performed on 756 patients were included in the study. Survival increased with growing experience during the study period. One hundred thirty-eight patients survived ≥30 y, of whom 35 (25%) received >1 graft. Chronic kidney disease was observed in 96 recipients (70%), necessitating additional kidney transplants in 16 patients (12%). De novo malignancy was diagnosed in 31 patients (23%; 4% after pediatric and 33% after adult LT, Conclusions: This is the first study offering detailed insight into LT survival beyond 30 y. The data show that 30-y survival after LT is reachable in relevant numbers, with stable graft function and the opportunity to live an active, self-directed life.

Identifiers

PMID42781687
PMCPMC13600577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.